Tempus AI is trading at $81.81, up 4.24% at 10:41 a.m. EST on November 3, 2026, following its November 2 Q3 report and raised guidance, which were reported as prompting investor optimism.
- Revenue rose 23% to $411.5 million; adjusted EBITDA was $25.6 million.
- Management raised 2026 revenue guidance to $1.60–$1.605 billion.
- MRD testing volume increased 300% to about 12,000 tests.